Alnylam Pharmaceuticals ALNY
$143.82 −$4.00 (-2.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $144.50 +0.47%
Open$148.35
Prev close$147.82
Day range$143.40 – $151.41
Volume2.33M
Market cap$19.26B
P/E (TTM)7.5
Dividend yield–
Analyst view
ConsensusBuy
Analysts25
Average target$297.59+106.9% vs. price
- Buy 76%
- Hold 24%
Low $199.00Now $143.82Avg $297.59High $410.00
Recent rating changes
The last 20 actions on file set price targets from $199.00 to $455.00, averaging $312.42.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 20 Nov 2026 | BMO Capital | BUY | $293.00 |
| 18 Nov 2026 | J.P. Morgan | BUY | $254.00 |
| 17 Nov 2026 | Cantor Fitzgerald | HOLD | $205.00 |
| 17 Nov 2026 | H.C. Wainwright | BUY | $250.00 |
| 11 Nov 2026 | H.C. Wainwright | BUY | $455.00 |
| 10 Nov 2026 | Piper Sandler | BUY | $410.00 |
| 10 Nov 2026 | Citi | BUY | $250.00 |
| 9 Nov 2026 | Citi | BUY | $250.00 |
| 6 Nov 2026 | Cantor Fitzgerald | HOLD | $290.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $455.00 |
| 5 Nov 2026 | Piper Sandler | BUY | $410.00 |
| 5 Nov 2026 | BofA Securities | BUY | – |
| 5 Nov 2026 | BMO Capital | BUY | $292.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $455.00 |
| 5 Nov 2026 | Oppenheimer | BUY | $320.00 |
| 4 Nov 2026 | Wells Fargo | HOLD | $220.00 |
| 2 Nov 2026 | CCORF | BUY | $323.00 |
| 2 Nov 2026 | Truist Financial | HOLD | $225.00 |
| 2 Nov 2026 | Barclays | BUY | $380.00 |
| 30 Oct 2026 | Bernstein | HOLD | $199.00 |
No comments yet — be the first to weigh in on ALNY.
Sign in to join the discussion.